Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials.
- DOI
- 10.1002/acr2.11156
- Published
- 2020 Aug
- Container
- ACR open rheumatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/acr2.11156,
title = {Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials.},
author = {Mease PJ and Gladman DD and Gomez-Reino JJ and Hall S and Kavanaugh A and Lespessailles E and Schett G and Paris M and Delev N and Teng L and Wollenhaupt J},
year = {2020},
journal = {ACR open rheumatology},
doi = {10.1002/acr2.11156},
url = {https://doi.org/10.1002/acr2.11156}
}RIS
TY - JOUR TI - Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials. AU - Mease PJ AU - Gladman DD AU - Gomez-Reino JJ AU - Hall S AU - Kavanaugh A AU - Lespessailles E AU - Schett G AU - Paris M AU - Delev N AU - Teng L AU - Wollenhaupt J PY - 2020 JO - ACR open rheumatology DO - 10.1002/acr2.11156 UR - https://doi.org/10.1002/acr2.11156 ER -
APA
PJ, M., DD, G., JJ, G., S, H., A, K., E, L., G, S., M, P., N, D., L, T., & J, W. (2020). Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials.. ACR open rheumatology. https://doi.org/10.1002/acr2.11156
Source records
- pubmed · retrieved 2026-09-26T02:37:28.473Z
- europe-pmc · retrieved 2026-09-26T02:37:28.487Z
- doaj · retrieved 2026-09-26T02:37:28.482Z
- hal · retrieved 2026-09-26T02:37:28.530Z